Literature DB >> 25754090

Tregs in gliomas - the jury is still out.

Michael Platten1, Wolfgang Wick1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25754090      PMCID： PMC4483128          DOI： 10.1093/neuonc/nov034

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  15 in total

1.  An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

2.  A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Authors:  James Schuster; Rose K Lai; Lawrence D Recht; David A Reardon; Nina A Paleologos; Morris D Groves; Maciej M Mrugala; Randy Jensen; Joachim M Baehring; Andrew Sloan; Gary E Archer; Darell D Bigner; Scott Cruickshank; Jennifer A Green; Tibor Keler; Thomas A Davis; Amy B Heimberger; John H Sampson
Journal:  Neuro Oncol       Date:  2015-01-13       Impact factor: 12.300

3.  Genetic basis for clinical response to CTLA-4 blockade in melanoma.

Authors:  Alexandra Snyder; Vladimir Makarov; Taha Merghoub; Jianda Yuan; Jedd D Wolchok; Timothy A Chan; Jesse M Zaretsky; Alexis Desrichard; Logan A Walsh; Michael A Postow; Phillip Wong; Teresa S Ho; Travis J Hollmann; Cameron Bruggeman; Kasthuri Kannan; Yanyun Li; Ceyhan Elipenahli; Cailian Liu; Christopher T Harbison; Lisu Wang; Antoni Ribas
Journal:  N Engl J Med       Date:  2014-11-19       Impact factor: 91.245

4.  A vaccine targeting mutant IDH1 induces antitumour immunity.

Authors:  Theresa Schumacher; Lukas Bunse; Stefan Pusch; Felix Sahm; Benedikt Wiestler; Jasmin Quandt; Oliver Menn; Matthias Osswald; Iris Oezen; Martina Ott; Melanie Keil; Jörg Balß; Katharina Rauschenbach; Agnieszka K Grabowska; Isabel Vogler; Jan Diekmann; Nico Trautwein; Stefan B Eichmüller; Jürgen Okun; Stefan Stevanović; Angelika B Riemer; Ugur Sahin; Manuel A Friese; Philipp Beckhove; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

5.  Proximity ligation assay evaluates IDH1R132H presentation in gliomas.

Authors:  Lukas Bunse; Theresa Schumacher; Felix Sahm; Stefan Pusch; Iris Oezen; Katharina Rauschenbach; Marina Gonzalez; Gergely Solecki; Matthias Osswald; David Capper; Benedikt Wiestler; Frank Winkler; Christel Herold-Mende; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

6.  Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

Authors:  Valérie Dutoit; Christel Herold-Mende; Norbert Hilf; Oliver Schoor; Philipp Beckhove; Judith Bucher; Katharina Dorsch; Sylvia Flohr; Jens Fritsche; Peter Lewandrowski; Jennifer Lohr; Hans-Georg Rammensee; Stefan Stevanovic; Claudia Trautwein; Verona Vass; Steffen Walter; Paul R Walker; Toni Weinschenk; Harpreet Singh-Jasuja; Pierre-Yves Dietrich
Journal:  Brain       Date:  2012-03-14       Impact factor: 13.501

7.  Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

Authors:  Amy B Heimberger; Mohamed Abou-Ghazal; Chantal Reina-Ortiz; David S Yang; Wei Sun; Wei Qiao; Nobuyoshi Hiraoka; Gregory N Fuller
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

8.  FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration.

Authors:  Véronique Frattini; Federica Pisati; Maria Carmela Speranza; Pietro Luigi Poliani; Gianmaria Frigé; Gabriele Cantini; Dimos Kapetis; Manuela Cominelli; Alessandra Rossi; Gaetano Finocchiaro; Serena Pellegatta
Journal:  Oncotarget       Date:  2012-09-22

9.  Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Authors:  Surasak Phuphanich; Christopher J Wheeler; Jeremy D Rudnick; Mia Mazer; Hongqian Wang; Miriam A Nuño; Jaime E Richardson; Xuemo Fan; Jianfei Ji; Ray M Chu; James G Bender; Elma S Hawkins; Chirag G Patil; Keith L Black; John S Yu
Journal:  Cancer Immunol Immunother       Date:  2012-07-31       Impact factor: 6.968

10.  Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.

Authors:  S Han; C Zhang; Q Li; J Dong; Y Liu; Y Huang; T Jiang; A Wu
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640
View more
  2 in total

Review 1.  Role of AHR and HIF-1α in Glioblastoma Metabolism.

Authors:  Galina Gabriely; Michael A Wheeler; Maisa C Takenaka; Francisco J Quintana
Journal:  Trends Endocrinol Metab       Date:  2017-03-16       Impact factor: 12.015

2.  Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.

Authors:  Ioannis Kaffes; Frank Szulzewsky; Zhihong Chen; Cameron J Herting; Ben Gabanic; José E Velázquez Vega; Jennifer Shelton; Jeffrey M Switchenko; James L Ross; Leon F McSwain; Jason T Huse; Bengt Westermark; Sven Nelander; Karin Forsberg-Nilsson; Lene Uhrbom; Naga Prathyusha Maturi; Patrick J Cimino; Eric C Holland; Helmut Kettenmann; Cameron W Brennan; Daniel J Brat; Dolores Hambardzumyan
Journal:  Oncoimmunology       Date:  2019-08-22       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.